drugset / Press release
Astex Pharmaceuticals Announces Presentation of Updated Results of SGI-110-01 Study inPatients With Intermediate or High Risk Relapsed or Refractory Myelodysplastic Syndromes at the European Hematology Association
2013-06-14 · Astex Pharmaceuticals, Inc. · original astx.com ↗
Astex Pharmaceuticals Announces Presentation of Updated Results of SGI-110-01 Study in Patients With Intermediate or High Risk Relapsed or Refractory Myelodysplastic Syndromes at the European Hematology Association
The release as fetched from its publisher. astx.com ↗